A randomized prospective clinical trial comparing OsteoActivator-P coated membranes vs Collagen Membrane-P uncoated for accelerated localized alveolar ridge preservation.

Osteo Pharma0 个研究点目标入组 16 人开始时间: 待定最近更新: 2024年6月11日

试验速览

暂无简介。

•Males and females, aged =18 years.
•Patient has signed informed consent.
•Patients with a ruinous dentition (including the canines) in the lower jaw in need of extractions of all teeth of the mandible.
•Patients in need of a total dental prosthesis in the lower jaw.
•Patients that want an implant-based denture in the lower jaw.
•Bone width of at least 7mm
•Bone height beneath the root-point of the canines at least 10mm

•Absence of the lower canines
•History of treatment with bisphosphonates or denosumab
•History of radiotherapy in the head/neck region
•Poor oral hygiene
•Women who are pregnant or breastfeeding
•Compromised immune system (e.g. uncontrolled diabetis) or unstable bleeding disorder.
•Patients with ASA classification of III or worse
•Local infection at the site of implantation
•History of previous ridge augmentation/preservation at the site of interest
•History of oral cancer or radiation of the oral cavity.
•Current malignancy
•Unresolved oral pathologies
•Refusing the implantation of porcine material
•Highly atrophic mandible (Cawood classification V or higher)
•Known allergy to collagen.
•Heavy smoking (> 20 cigarettes/day).

发起方

Osteo Pharma